Investors were surely discovering drug discovery company AbCellera Biologics (NASDAQ: ABCL) as the trading week kicked off on ...

The FWC found that the letter of 11 January 2023 constituted a valid contract variation. The Commission stated: "This letter ...

Grundy advises companies to keep communication open, move quickly, and showcase company culture and career growth early in ...

Generation Investment Management, an investment management firm, released its “Global Equity Strategy” first quarter 2025 ...

Despite hiring a commercial chief and sponsoring disease awareness efforts last year, Savara will have to wait a while longer ...

Savara Receives Refusal to File (RTF) Letter From the U.S. Food and Drug Administration (FDA) for the Biologics License Application ... SVRA) (the Company), a clinical-stage biopharmaceutical ...

Plans for a 35-metre-high telecoms tower at a Sunderland business park have been submitted to council development bosses.

The website you are visiting is protected and accelerated by Imperva. Your computer may have been infected by malware and ...

Sec. 541 imposes a 20% tax on the undistributed personal holding company income of a personal holding company. Initially ...

Instead, Stealth submitted a new drug application seeking approval of elamipretide, and the FDA issued its refusal-to-file ...

The O1 visa is a prestigious nonimmigrant visa granted to individuals who demonstrate extraordinary ability in their field, whether it be the arts, sciences, education, business, or athletics. While ...

Studio 17’s Job Corner, in partnership with Cazador Consulting Group, is your go-to resource for career growth. This week, ...